These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 25003010)
1. From an orphan disease to a generalized molecular mechanism: PTPN11 loss-of-function mutations in the pathogenesis of metachondromatosis. Yang W; Neel BG Rare Dis; 2013; 1():e26657. PubMed ID: 25003010 [TBL] [Abstract][Full Text] [Related]
2. Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling. Yang W; Wang J; Moore DC; Liang H; Dooner M; Wu Q; Terek R; Chen Q; Ehrlich MG; Quesenberry PJ; Neel BG Nature; 2013 Jul; 499(7459):491-5. PubMed ID: 23863940 [TBL] [Abstract][Full Text] [Related]
3. Targeted disruption of Shp2 in chondrocytes leads to metachondromatosis with multiple cartilaginous protrusions. Kim HK; Feng GS; Chen D; King PD; Kamiya N J Bone Miner Res; 2014 Mar; 29(3):761-9. PubMed ID: 23929766 [TBL] [Abstract][Full Text] [Related]
4. Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2. Solman M; Woutersen DTJ; den Hertog J Front Cell Dev Biol; 2022; 10():1046415. PubMed ID: 36407105 [TBL] [Abstract][Full Text] [Related]
6. [The Biological Function of SHP2 in Human Disease]. Li SM Mol Biol (Mosk); 2016; 50(1):27-33. PubMed ID: 27028808 [TBL] [Abstract][Full Text] [Related]
7. Targeted Ptpn11 deletion in mice reveals the essential role of SHP2 in osteoblast differentiation and skeletal homeostasis. Wang L; Yang H; Huang J; Pei S; Wang L; Feng JQ; Jing D; Zhao H; Kronenberg HM; Moore DC; Yang W Bone Res; 2021 Jan; 9(1):6. PubMed ID: 33500396 [TBL] [Abstract][Full Text] [Related]
8. Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome. Bowen ME; Boyden ED; Holm IA; Campos-Xavier B; Bonafé L; Superti-Furga A; Ikegawa S; Cormier-Daire V; Bovée JV; Pansuriya TC; de Sousa SB; Savarirayan R; Andreucci E; Vikkula M; Garavelli L; Pottinger C; Ogino T; Sakai A; Regazzoni BM; Wuyts W; Sangiorgi L; Pedrini E; Zhu M; Kozakewich HP; Kasser JR; Seidman JG; Kurek KC; Warman ML PLoS Genet; 2011 Apr; 7(4):e1002050. PubMed ID: 21533187 [TBL] [Abstract][Full Text] [Related]
10. The Cell-Specific Role of SHP2 in Regulating Bone Homeostasis and Regeneration Niches. Zhang J; Ye C; Zhu Y; Wang J; Liu J Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768520 [TBL] [Abstract][Full Text] [Related]
11. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238 [TBL] [Abstract][Full Text] [Related]
12. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Chan G; Kalaitzidis D; Neel BG Cancer Metastasis Rev; 2008 Jun; 27(2):179-92. PubMed ID: 18286234 [TBL] [Abstract][Full Text] [Related]
13. Metachondromatosis: A Confusing Disease. Blasco A; Salom M; Giner F; Baixauli E; Baixauli F Rev Bras Ortop (Sao Paulo); 2024 Jul; 59(Suppl 1):e26-e30. PubMed ID: 39027184 [TBL] [Abstract][Full Text] [Related]
14. EXT-related pathways are not involved in the pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis. Bovée JV; Hameetman L; Kroon HM; Aigner T; Hogendoorn PC J Pathol; 2006 Jul; 209(3):411-9. PubMed ID: 16622899 [TBL] [Abstract][Full Text] [Related]
15. Gain-of-function mutations of Ptpn11 (Shp2) cause aberrant mitosis and increase susceptibility to DNA damage-induced malignancies. Liu X; Zheng H; Li X; Wang S; Meyerson HJ; Yang W; Neel BG; Qu CK Proc Natl Acad Sci U S A; 2016 Jan; 113(4):984-9. PubMed ID: 26755576 [TBL] [Abstract][Full Text] [Related]
16. Recapitulation of the parathyroid hormone-related peptide-Indian hedgehog pathway in the regenerating deer antler. Faucheux C; Nicholls BM; Allen S; Danks JA; Horton MA; Price JS Dev Dyn; 2004 Sep; 231(1):88-97. PubMed ID: 15305289 [TBL] [Abstract][Full Text] [Related]
17. Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated malignancies. Yu B; Liu W; Yu WM; Loh ML; Alter S; Guvench O; Mackerell AD; Tang LD; Qu CK Mol Cancer Ther; 2013 Sep; 12(9):1738-48. PubMed ID: 23825065 [TBL] [Abstract][Full Text] [Related]
18. Protein Tyrosine Phosphatase Non-Receptor 11 ( Richards CE; Elamin YY; Carr A; Gately K; Rafee S; Cremona M; Hanrahan E; Smyth R; Ryan D; Morgan RK; Kennedy S; Hudson L; Fay J; O'Byrne K; Hennessy BT; Toomey S Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445722 [No Abstract] [Full Text] [Related]
19. Structural Determinants of Phosphopeptide Binding to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase. Anselmi M; Calligari P; Hub JS; Tartaglia M; Bocchinfuso G; Stella L J Chem Inf Model; 2020 Jun; 60(6):3157-3171. PubMed ID: 32395997 [TBL] [Abstract][Full Text] [Related]
20. Developmental pathways in musculoskeletal neoplasia: involvement of the Indian Hedgehog-parathyroid hormone-related protein pathway. Tiet TD; Alman BA Pediatr Res; 2003 Apr; 53(4):539-43. PubMed ID: 12612211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]